Saturday 17 October 2026
Export PPBT’s income statement to Excel — free account
Purple Biotech Ltd. Sponsored ADR
PPBT Healthcare Biotechnology
In the quarter to June 2026, EPS grew 110.2% and free cash flow fell 62.1%, each against the same quarter a year earlier.
1.14
0.09
−7.32%
Follow PPBT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 2 | — | — | — | — | — | — |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Altman Z-Score |
— | (3.90) | (3.90) | (3.51) | 5.49 | — | — | — | — | — |
P/S ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
— | (11.00) | (7.82) | (9.16) | 20.99 | — | — | — | — | — |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Beneish M-Score |
— | — | — | (1.78) | — | — | — | — | — | — |
P/Operating CF |
— | 0.00 | 0.00 | (549.01) | (1,089.68) | — | — | — | — | — |
P/B ratio |
— | 0.00 | 0.00 | 282.16 | 165.93 | — | — | — | — | — |
Price to Tangible BV |
— | 0.00 | 0.00 | 653.72 | 223.63 | — | — | — | — | — |
EV/Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
— | 0.31 | 0.25 | (154.36) | (533.66) | — | — | — | — | — |
EV/FCF |
— | 0.31 | 0.25 | (154.05) | (529.55) | — | — | — | — | — |
Quick Ratio |
11.63 | 1.87 | 2.24 | 2.22 | 18.82 | 11.41 | 4.55 | 1.59 | 2.14 | 1.23 |
Current Ratio |
11.70 | 2.01 | 2.57 | 2.34 | 19.14 | 11.41 | 4.71 | 1.63 | 2.23 | 1.27 |
Net Debt/EBITDA |
2.04 | 0.62 | 0.85 | 0.92 | 4.45 | 2.67 | 1.43 | 0.70 | 0.79 | 0.35 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.01 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.52 | 0.71 | 1.63 | 0.95 | 0.49 | 0.81 | 0.77 | 1.00 | 1.98 | 0.21 |
Capex/Depreciation |
(5.00) | (3.25) | (2.29) | (0.06) | (0.66) | (0.50) | (1.13) | (0.02) | 0.00 | (0.01) |
Interest Coverage |
(117.75) | (460.23) | (13.59) | (39.54) | (217.03) | (84.59) | (337.36) | (10.15) | (22.78) | (27.96) |
| (106.29%) | (110.33%) | (52.81%) | (53.52%) | (61.80%) | (25.38%) | (38.62%) | (48.85%) | (21.55%) | (123.97%) | |
| (94.26%) | (83.70%) | (35.98%) | (39.74%) | (56.84%) | (23.88%) | (34.72%) | (40.19%) | (17.80%) | (96.63%) | |
ROIC |
0.00% | (596.87%) | (113.22%) | (100.19%) | (37.70%) | (62.60%) | (94.27%) | (73.71%) | (28.20%) | (20,189.71%) |
Return on Tangible Assets |
(88.89%) | (301.56%) | (99.29%) | (122.03%) | (49.68%) | (41.31%) | (82.04%) | (318.54%) | (143.51%) | (1,179.53%) |
Average Days of Receivables |
0.00 | 0.00 | 270.24 | 544.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 4,640.00% | 526.80% | 267.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 6,397.00% | 519.50% | 607.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.44 | 0.42 | 0.42 | 0.24 | 0.29 | 0.38 | 0.63 | 0.75 | 0.42 |
Share Based Compensation of Revenue |
0.00% | 2,308.00% | 77.30% | 127.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Earnings Yield |
— | (199.77%) | (0.32%) | (4.22%) | (0.06%) | — | — | — | — | — |
Free Cash Flow Yield |
— | 0.00% | 0.00% | (0.65%) | (0.19%) | — | — | — | — | — |
Revenue per Share |
0.00 | 21.28 | 140.85 | 103.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2,159.31) | (1,835.53) | (1,194.37) | (575.36) | (239.95) | (169.44) | (185.12) | (179.99) | (87.60) | (11.78) |
Capex per Share |
(3.45) | (2.77) | (2.25) | (1.13) | (2.71) | (1.31) | (2.52) | (0.03) | 0.00 | (0.01) |
Free Cash Flow per Share |
(2,162.76) | (1,838.30) | (1,196.62) | (576.49) | (242.66) | (170.75) | (187.64) | (180.02) | (87.60) | (11.79) |
Cash per Share |
5,054.14 | 1,581.91 | 941.41 | 659.28 | 1,005.30 | 537.59 | 355.23 | 139.22 | 51.98 | 19.94 |
Shareholders Equity per Share |
4,615.52 | 1,848.51 | 1,549.86 | 1,119.48 | 1,386.99 | 741.53 | 521.00 | 309.82 | 200.68 | 20.12 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4,615.52 | 1,848.51 | 1,549.86 | 1,119.48 | 1,386.99 | 741.53 | 521.00 | 309.82 | 200.68 | 20.12 |
Free Cash Flow |
(6.27) | (8.64) | (8.50) | (5.59) | (13.95) | (14.99) | (16.96) | (19.93) | (14.37) | (5.66) |
Working Capital |
13.63 | 4.01 | 5.20 | 4.76 | 56.18 | 44.22 | 26.20 | 6.09 | 4.92 | 2.11 |
Capital Expenditures |
(0.01) | (0.01) | (0.02) | (0.01) | (0.16) | (0.11) | (0.23) | 0.00 | — | 0.00 |
Net Current Asset Value |
13.37 | 2.49 | 4.80 | 4.44 | 55.23 | 43.38 | 25.73 | 5.78 | 4.78 | 1.95 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.00 | 0.13 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.13 | 0.14 | 0.19 | 4.68 | 1.32 | 0.83 | 0.93 | 1.28 | 1.50 | 1.64 |
Cash ROIC |
(22.37%) | (53.59%) | (48.03%) | (32.41%) | (10.14%) | (13.35%) | (21.41%) | (40.09%) | (34.67%) | (29.42%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 2.24 | 0.90 | 0.00 | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.20 | — | 0.45 | 1.12 | 1.00 | 0.89 | 1.21 | — | — | — |
Average Payables |
0.43 | 0.37 | 0.46 | 0.98 | 1.22 | 1.34 | 1.80 | 2.83 | 2.49 | 1.76 |
Average Assets |
12.86 | 14.55 | 14.45 | 14.72 | 49.26 | 77.00 | 62.41 | 49.46 | 40.67 | 27.31 |
Average Common Equity |
11.41 | 11.04 | 9.85 | 10.93 | 45.31 | 72.43 | 56.10 | 40.70 | 33.60 | 21.29 |
Columns are period end dates